Tobevibart
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Tobevibart, covering 2026-01-16 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection [Phase 3]